Details

NameSymbolSector
VIVANZA BIOSCIENCES LIMITEDVIVANZAPharmaceuticals
Open
1.6
High
1.7
Low
1.6
Close
1.7
Volume
31732
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Vivanza Biosciences is  
Marubozu
Estimated Stoploss of Vivanza Biosciences is ₹  
1.6
Vivanza Biosciences has a  
Bullishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Vivanza Biosciences has chances of  
Continuationℹ
 of the current trend. 

Trend

Vivanza Biosciences is in  
Sideways trendℹ
. 
Price of Vivanza Biosciences is  
Downℹ
 by  

6.08

%. 
Target
Buy @ 

1.64

Sell @ 

1.98

Current @ 

1.7

Volume

The trades of Vivanza Biosciences have been in  
Immenseℹ
 volume. 
The volume trades for Vivanza Biosciences are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Vivanza Biosciences is  

Up

 by  

51.16

% 

Valuation

The current market price of Vivanza Biosciences is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 16cr and total assets worth ₹ 16cr, the balance sheet of Vivanza Biosciences is:  
Balancedℹ
. 
Cashflow
Vivanza Biosciences has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 2cr spent in operatingℹ
0% in investingℹ
50% i.e. ₹ 2cr earned in financingℹ
0% in otherℹ
Vivanza Biosciences has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

66.67% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
33.33% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Income
The income of Vivanza Biosciences is  

₹ 55cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Vivanza Biosciences Losses increased by:  

0

% and Income is Up by:  

587.5

% 

(*Sep 2025)

The income of Vivanza Biosciences is  

₹ 8cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Vivanza Biosciences Losses decreased by:  

100

% and Income is Up by:  

800

% 

(*Jun 2025)

The income of Vivanza Biosciences is  

₹ 0cr

 and  

Loss

 is :  

₹ 1cr

(*Mar 2025)

Vivanza Biosciences Losses increased by:  

100

% and Income is Down by:  

100

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.